Annual Report

The report records Chugai's first year with revenue above one trillion yen and its sixth consecutive record-breaking year. The company continued its TOP I 2030 strategy, focused on doubling R&D output and launching in-house global products annually. It also reports first place globally in the pharmaceutical sector in DJSI World and says it exceeded its 2025 emissions-reduction milestone ahead of schedule.